Pompey, France (ots/PRNewswire) - Groupe Novasep is pleased to
announce that Mr Thierry Favreau has been appointed President of its
Novasep Process business.
Thierry graduated from EDHEC and held several management and senor
executive positions within Baxter, Becton Dickinson and
Sanofi-Synthelabo. Prior to joining Groupe Novasep Thierry Favreau
was CEO of Stedim Group..
"Growth will be driven by the development of a unique
products/systems/services offering based on the expertise and state
of the art technologies from Novasep Process companies:Applexion,
Orelis and Novasep SAS" said Thierry Favreau.
Novasep Process offers solutions for producing pure products, from
process development to optimization, from the supply of laboratory
purification equipment to the delivery of industrial turn-key
purification plants. Novasep Process meets the very specific needs of
the Pharmaceutical, Biopharmaceutical and Agrobio industries.
Groupe Novasep, headquartered in Pompey, France, binds chemical
synthesis and chemical engineering expertise in order to develop new
technologies. The group operates through two business units: Novasep
Synthesis and Novasep Process, focusing on the synthesis and process
of active pharmaceutical and biopharmaceutical ingredients.
Jean-Marc Le Rudulier
Marketing & Communication Director
Bd de la Moselle
Tel : +33-(0)3-83-49-71-46
Mob : +33-(0)6-87-69-06-57
Fax : +33-(0)3-83-49-71-40
ots Originaltext: Novasep
Im Internet recherchierbar: http://www.presseportal.ch
Press contact: Jean-Marc Le Rudulier, Marketing & Communication
Director, Groupe Novasep, Bd de la Moselle, B.P. 50, 54340 Pompey,
France, Tel : +33-(0)3-83-49-71-46, Mob : +33-(0)6-87-69-06-57, Fax :